======= HSD11B1 ======= == Gene Information == * **Official Symbol**: HSD11B1 * **Official Name**: hydroxysteroid 11-beta dehydrogenase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3290|3290]] * **UniProt**: [[https://www.uniprot.org/uniprot/P28845|P28845]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HSD11B1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HSD11B1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600713|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a microsomal enzyme that catalyzes the conversion of the stress hormone cortisol to the inactive metabolite cortisone. In addition, the encoded protein can catalyze the reverse reaction, the conversion of cortisone to cortisol. Too much cortisol can lead to central obesity, and a particular variation in this gene has been associated with obesity and insulin resistance in children. Mutations in this gene and H6PD (hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)) are the cause of cortisone reductase deficiency. Alternate splicing results in multiple transcript variants encoding the same protein.[provided by RefSeq, May 2011]. * **UniProt Summary**: Catalyzes reversibly the conversion of cortisol to the inactive metabolite cortisone. Catalyzes reversibly the conversion of 7-ketocholesterol to 7-beta-hydroxycholesterol. In intact cells, the reaction runs only in one direction, from 7- ketocholesterol to 7-beta-hydroxycholesterol (By similarity). {ECO:0000250}. |adh short| |KR| |11-beta-hydroxysteroid dehydrogenase (NADP+) activity| |11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity| |glucocorticoid biosynthetic process| |glucocorticoid metabolic process| |steroid binding| |steroid hormone biosynthetic process| |hormone biosynthetic process| |steroid biosynthetic process| |lung development| |respiratory tube development| |respiratory system development| |hormone metabolic process| |steroid metabolic process| |regulation of hormone levels| |lipid biosynthetic process| |tube development| |endoplasmic reticulum membrane| |oxidation-reduction process| |lipid metabolic process| |organic cyclic compound biosynthetic process| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp263|Aphidicolin 0.04μM R06 exp263]]|-1.81| |[[:results:exp151|SGC0946 7μM R03 exp151]]|-1.7| |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|1.93| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.531| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4665 * **Expression level (log2 read counts)**: -5.6 {{:chemogenomics:nalm6 dist.png?nolink |}}